186 related articles for article (PubMed ID: 30379726)
1. Incidence and prognosis of brain metastases in cutaneous melanoma patients: a population-based study.
Zhang D; Wang Z; Shang D; Yu J; Yuan S
Melanoma Res; 2019 Feb; 29(1):77-84. PubMed ID: 30379726
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of brain metastases in cutaneous head and neck melanoma.
Daryanani D; Plukker JT; de Jong MA; Haaxma-Reiche H; Nap R; Kuiper H; Hoekstra HJ
Melanoma Res; 2005 Apr; 15(2):119-24. PubMed ID: 15846145
[TBL] [Abstract][Full Text] [Related]
3. Primary melanoma location on the scalp is an important risk factor for brain metastasis: a study of 1,687 patients with cutaneous head and neck melanomas.
Huismans AM; Haydu LE; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Thompson JF
Ann Surg Oncol; 2014 Nov; 21(12):3985-91. PubMed ID: 24912613
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of a nomogram for melanomas with brain metastases at initial diagnosis.
Liu H; Xu YB; Guo CC; Li MX; Ji JL; Dong RR; Zhang LL; He XX
Cancer Med; 2019 Dec; 8(18):7577-7585. PubMed ID: 31657530
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for development of melanoma brain metastasis and disease progression: a single-center retrospective analysis.
Gardner LJ; Ward M; Andtbacka RHI; Boucher KM; Bowen GM; Bowles TL; Cohen AL; Grossmann K; Hitchcock YJ; Holmen SL; Hyngstrom J; Khong H; McMahon M; Monroe MM; Ross CB; Suneja G; Wada D; Grossman D
Melanoma Res; 2017 Oct; 27(5):477-484. PubMed ID: 28800031
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW; Rizzo M
Am J Clin Oncol; 2014 Dec; 37(6):580-4. PubMed ID: 23428955
[TBL] [Abstract][Full Text] [Related]
7. Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features.
Raizer JJ; Hwu WJ; Panageas KS; Wilton A; Baldwin DE; Bailey E; von Althann C; Lamb LA; Alvarado G; Bilsky MH; Gutin PH
Neuro Oncol; 2008 Apr; 10(2):199-207. PubMed ID: 18287337
[TBL] [Abstract][Full Text] [Related]
8. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
Tas F; Kurul S; Camlica H; Topuz E
Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
[TBL] [Abstract][Full Text] [Related]
9. Brain metastases in adult patients with melanoma of unknown primary in the Netherlands (2011-2020).
Padilla CS; Ho VKY; Mooijenkind TWAN; Louwman MWJ; de Vos FYFL; Bekkenk MW; Minnaard WA; Loef C; van Zanten SEMV
J Neurooncol; 2023 May; 163(1):239-248. PubMed ID: 37169949
[TBL] [Abstract][Full Text] [Related]
10. Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer.
Jin J; Gao Y; Zhang J; Wang L; Wang B; Cao J; Shao Z; Wang Z
BMC Cancer; 2018 Apr; 18(1):446. PubMed ID: 29673325
[TBL] [Abstract][Full Text] [Related]
11. Intracerebral metastases of malignant melanoma and their recurrences--a clinical analysis.
Miller D; Zappala V; El Hindy N; Livingstone E; Schadendorf D; Sure U; Sandalcioglu IE
Clin Neurol Neurosurg; 2013 Sep; 115(9):1721-8. PubMed ID: 23643143
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth A; Wanek LA; Morton DL
J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors and epidemiological characteristics of cutaneous and mucosal head and neck melanoma.
Berzina A; Azarjana K; Cema I; Pjanova D; Rivosh A
Stomatologija; 2011; 13(2):49-54. PubMed ID: 21822045
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and incidence of primary mucosal melanoma: a population-based study in France.
Beaudoux O; Riffaud L; Barbe C; Grange F
Eur J Dermatol; 2018 Oct; 28(5):654-660. PubMed ID: 30378540
[TBL] [Abstract][Full Text] [Related]
15. The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.
Sun M; De Velasco G; Brastianos PK; Aizer AA; Martin A; Moreira R; Nguyen PL; Trinh QD; Choueiri TK
Eur Urol Focus; 2019 May; 5(3):474-481. PubMed ID: 29311016
[TBL] [Abstract][Full Text] [Related]
16. Melanoma of the external ear: A population-based study.
Deep NL; Glasgow AE; Habermann EB; Kasperbauer JL; Carlson ML
Am J Otolaryngol; 2017; 38(3):309-315. PubMed ID: 28258767
[TBL] [Abstract][Full Text] [Related]
17. Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute.
Katz KA; Jonasch E; Hodi FS; Soiffer R; Kwitkiwski K; Sober AJ; Haluska FG
Melanoma Res; 2005 Feb; 15(1):77-82. PubMed ID: 15714125
[TBL] [Abstract][Full Text] [Related]
18. Population-based validation of the National Cancer Comprehensive Network recommendations for baseline imaging workup of cutaneous melanoma.
Abdel-Rahman O
Melanoma Res; 2019 Feb; 29(1):53-58. PubMed ID: 30362976
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
Bedikian AY; Wei C; Detry M; Kim KB; Papadopoulos NE; Hwu WJ; Homsi J; Davies M; McIntyre S; Hwu P
Am J Clin Oncol; 2011 Dec; 34(6):603-10. PubMed ID: 21150567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
